A range of these complexes has been shown to have high in vitro biological activity (comparable with or better than cisplatin) against L1210 leukaemia, the corresponding cisplatin resistant line, and a human ovarian cell line, SKOV-3. However, initial in vivo testing against a solid mouse plasmacytoma (PC6) and P388 leukaemia has not revealed significant activity.
Introduction
It has been shown recently that metathetical reactions of Ph2BiX and PhBiX2 (X CI, Br, or I) with sodium quinolin-8-olate (NaOx) are complicated by rearrangement reactions and by incomplete elimination of sodium halides [1] . Typically bimetallics of composition PhBi(Ox)2(NaX)n were isolated together with varying amounts of Bi(Ox)3. However, halide-free PhBi(Ox)2 was isolated from the reaction of Ph2BiCI with Na(Ox) in the presence of 15-crown-5 and from reaction of PhBil2 with Bu4N(Ox). The low solubility of PhBi(Ox)2 suggested an associated structure but no clear structural conclusions could be drawn from spectroscopic data.
We now report the synthesis of a range of pure organobismuth quinolin-8-olate and 2-methylquinolin-8-olate complexes, RBi(Ox)2 and RBi(MeOx)2, the X-ray crystal structure of PhBi(MeOx)2 and a preliminary survey of the anti-cancer activity of these quinolin-8-olate complexes together with some related reference compounds.
There has been sporadic interest in antitumour properties of bismuth compounds [2] [3] [4] [5] [6] [7] the most successful of which have been methylbismuth(lll) thiolates. In addition, it has been shown that 8-quinolinol has antitumour activity [8, 9] . Bismuth compounds are much more widely used in the treatment of gastrointestinal disorders [7] and of peptic ulcers [10] . The low toxicity of most bismuth compounds, especially relative to that of many other heavy metal compounds, makes them attractive candidates for drug usage [7] . It has been observed, however, that regular ingestion of high doses of bismuth salts (5 15 g/day by many French citizens) led to ca 300 cases of bismuth(Ill) intoxication with some deaths in 1976 [11] .
Experimental
Instruments and Procedures Details have been described previously [1] . Reagents Sodium salts of quinolin-8-ol and 2-methylquinolin-8-ol were prepared as described previously [1] . The following diarylbismuth chlorides were prepared by reaction of stoichiometric amounts of BiCl3 and Ar3Bi [12] : Ph2BiCl, m.p. 185 400 nm. The solvent was removed from the filtrate to yield a pale yellow solid. This was extracted with water (6 x 10 ml) and ether (6 x 10 ml). NaCI (0.29 g, 98% by AgNO3 titration) was isolated from the aqueous washings. The solvent was removed from the ether extract to yield (4-MeC6H4)3Bi (1.13 g, 96%) identified by 1H nmr spectroscopy.
(4-ClC6H4)2BiCI + Na(Ox) A solution of Na(Ox) (0.50 g, 3 .0 mmol)in ethanol (20 ml) with 15-crown-5 ether (1.32 g, 1.2 ml, 6.0 mmol) was added to a solution of (4-CIC6H4)2BiCI (1.72 g, 3.7 mmol) in ethanol (40 ml). A yellow precipitate gradually appeared and the reaction mixture was stirred for 2 h. The yellow solid was collected by filtration, washed with ethanol (3 x 5 ml), light petroleum (3 x 10ml) and dried to yield an ethanol solvate of (4-chlorophenyl)bis(quinolin-8-olato)bismuth(lll) (0.91 g, 93%) (Found" C, 44.1; H, 2.7; CI, 5.4 The crown ether prevented retention of sodium chloride-by the arylbismuth oxinate [1] . In representative cases, the amount of sodium chloride produced was shown to be ca. 90% as was the yield of Ar3Bi. Reaction (1) (Table 5) , with the compound delivered intraperitoneally as a solution in Me2SO. Three separate concentrations were examined including the maximum tolerated dose but no activity was detected. These results contrast the reported in vivo activity of 6-mercaptopurinebismuth(lll) complexes [4] , the methylbismuth(lll) thiolates [7] , and, more closely relevant, Ph2BiO2CR (R Et, iPr or Ph) [6] , for which activity against P388 leukaemia (T/C 147-168% for doses of 50-200 mg/kg) was recorded [6] . Of relevance to the latter observation is that diphenylbismuth(lll) carboxylates have been shown to be highly sensitive to hydrolytic cleavage of aryl groups [30] . For PhBi(Ox or MeOx)2, the contrast between the excellent activity in vitro and the lack of activity in vivo is dramatic, and points to delivery problems in animal models. This has not been overcome by dissolution of the low solubility drugs in Me2SO, where precipitation on injection into aqueous biological fluids may deactivate the compounds. 
